Cardiovascular

FDA expands access to artificial heart valve to inoperable patients

On Sept. 23, the U.S. Food and Drug Administration (FDA) approved revised labeling for the Sapien Transcatheter Heart Valve (THV), making the device available to patients who have inoperable aortic valve stenosis. Read More.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares